MX387483B - Preparación farmacéutica. - Google Patents
Preparación farmacéutica.Info
- Publication number
- MX387483B MX387483B MX2017003945A MX2017003945A MX387483B MX 387483 B MX387483 B MX 387483B MX 2017003945 A MX2017003945 A MX 2017003945A MX 2017003945 A MX2017003945 A MX 2017003945A MX 387483 B MX387483 B MX 387483B
- Authority
- MX
- Mexico
- Prior art keywords
- pharmaceutical preparation
- salt
- aqueous composition
- light
- compound
- Prior art date
Links
- 239000000825 pharmaceutical preparation Substances 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 125000002183 isoquinolinyl group Chemical class C1(=NC=CC2=CC=CC=C12)* 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/1468—Containers characterised by specific material properties
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D81/00—Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents
- B65D81/24—Adaptations for preventing deterioration or decay of contents; Applications to the container or packaging material of food preservatives, fungicides, pesticides or animal repellants
- B65D81/30—Adaptations for preventing deterioration or decay of contents; Applications to the container or packaging material of food preservatives, fungicides, pesticides or animal repellants by excluding light or other outside radiation
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K3/00—Use of inorganic substances as compounding ingredients
- C08K3/18—Oxygen-containing compounds, e.g. metal carbonyls
- C08K3/20—Oxides; Hydroxides
- C08K3/22—Oxides; Hydroxides of metals
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K5/00—Use of organic ingredients
- C08K5/16—Nitrogen-containing compounds
- C08K5/34—Heterocyclic compounds having nitrogen in the ring
- C08K5/3467—Heterocyclic compounds having nitrogen in the ring having more than two nitrogen atoms in the ring
- C08K5/3472—Five-membered rings
- C08K5/3475—Five-membered rings condensed with carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K3/00—Use of inorganic substances as compounding ingredients
- C08K3/18—Oxygen-containing compounds, e.g. metal carbonyls
- C08K3/20—Oxides; Hydroxides
- C08K3/22—Oxides; Hydroxides of metals
- C08K2003/2237—Oxides; Hydroxides of metals of titanium
- C08K2003/2241—Titanium dioxide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Ophthalmology & Optometry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Mechanical Engineering (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Packages (AREA)
- Wrappers (AREA)
Abstract
Se provee una técnica para mejorar la estabilidad de un derivado halogenado de isoquinolina con respecto a la luz en una composición acuosa; una preparación farmacéutica obtenida al almacenar una composición acuosa que comprende un compuesto representado por la Fórmula (1): (ver Fórmula) en donde X representa un átomo de halógeno, o una sal del mismo, o un solvato del compuesto o la sal del mismo, en un envase que bloquea un rayo con una longitud de onda de 300 a 335 nm.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2014195279 | 2014-09-25 | ||
| PCT/JP2015/077015 WO2016047721A1 (ja) | 2014-09-25 | 2015-09-25 | 医薬製剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2017003945A MX2017003945A (es) | 2017-06-30 |
| MX387483B true MX387483B (es) | 2025-03-18 |
Family
ID=55581240
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2017003945A MX387483B (es) | 2014-09-25 | 2015-09-25 | Preparación farmacéutica. |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US20170304199A1 (es) |
| EP (1) | EP3199161B1 (es) |
| JP (6) | JP6244038B2 (es) |
| KR (1) | KR101846804B1 (es) |
| CN (1) | CN106794186B (es) |
| BR (1) | BR112017006149A2 (es) |
| CA (1) | CA2962628C (es) |
| DK (1) | DK3199161T3 (es) |
| ES (1) | ES2901997T3 (es) |
| HU (1) | HUE057834T2 (es) |
| MX (1) | MX387483B (es) |
| MY (1) | MY178371A (es) |
| PL (1) | PL3199161T3 (es) |
| PT (1) | PT3199161T (es) |
| SG (1) | SG11201702298VA (es) |
| TW (1) | TWI671071B (es) |
| WO (1) | WO2016047721A1 (es) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI686198B (zh) * | 2014-09-25 | 2020-03-01 | 日商興和股份有限公司 | 醫藥品 |
| JP6267839B1 (ja) * | 2016-06-15 | 2018-01-24 | 興和株式会社 | 水性組成物 |
| JP2019142773A (ja) * | 2016-06-15 | 2019-08-29 | 興和株式会社 | 眼科用組成物 |
| KR20230128395A (ko) * | 2017-02-28 | 2023-09-04 | 코와 가부시키가이샤 | 의약 제제 |
| EP3590513A4 (en) * | 2017-02-28 | 2020-12-30 | Kowa Company, Ltd. | DRUG |
| KR20230124753A (ko) | 2017-02-28 | 2023-08-25 | 코와 가부시키가이샤 | 의약품 |
| WO2018181294A1 (ja) * | 2017-03-27 | 2018-10-04 | 興和株式会社 | 医薬製剤 |
| WO2021195256A1 (en) * | 2020-03-24 | 2021-09-30 | Aerie Pharmaceuticals, Inc. | Pharmaceutical preparation |
| WO2023195543A1 (ja) * | 2022-04-08 | 2023-10-12 | 東亜薬品株式会社 | 眼科用水性組成物及び防腐効力を付与する方法 |
| JP7663792B1 (ja) * | 2024-07-22 | 2025-04-16 | 興和株式会社 | 医薬 |
| JP7783945B1 (ja) * | 2024-07-22 | 2025-12-10 | 興和株式会社 | 医薬 |
| WO2026022905A1 (ja) * | 2024-07-22 | 2026-01-29 | 興和株式会社 | 医薬 |
| JP7595233B1 (ja) * | 2024-07-22 | 2024-12-05 | 興和株式会社 | 医薬 |
| WO2026022906A1 (ja) * | 2024-07-22 | 2026-01-29 | 興和株式会社 | 医薬 |
| WO2026058384A1 (ja) * | 2024-09-12 | 2026-03-19 | 興和株式会社 | 医薬製剤 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3879940B2 (ja) * | 1995-07-11 | 2007-02-14 | 旭化成ファーマ株式会社 | 塩酸ファスジル注射剤 |
| US6602447B2 (en) * | 2001-08-21 | 2003-08-05 | Milliken & Company | Low-color ultraviolet absorbers for high UV wavelength protection applications |
| MY139797A (en) * | 2004-11-29 | 2009-10-30 | Kowa Co | (s)-(-)-1-(4-fluoroisoquinolin-5-yl)sulfonyl-2-methyl-1, 4-homopiperazine hydrochloride dihydrate |
| WO2006115244A1 (ja) * | 2005-04-25 | 2006-11-02 | D. Western Therapeutics Institute, Inc. | ４－ブロモイソキノリン誘導体及びこれを含有する医薬 |
| EP1905452B1 (en) * | 2005-07-12 | 2013-06-19 | Kowa Company, Ltd. | Agent for prevention or treatment of glaucoma |
| US20080064681A1 (en) * | 2006-09-11 | 2008-03-13 | Hiroyoshi Hidaka | Therapeutic agent for treating glaucoma |
| JPWO2008096804A1 (ja) * | 2007-02-07 | 2010-05-27 | テイカ製薬株式会社 | ラタノプロスト含有点眼剤 |
| US20110184017A1 (en) * | 2008-07-25 | 2011-07-28 | Asahi Kasei Pharma Corporation | Stable aqueous solution composition containing sulfonamide compound |
| US20160339018A1 (en) * | 2013-04-24 | 2016-11-24 | Kyushu University, National University Corporation | Therapeutic agent for ocular fundus disease |
| US10034885B2 (en) * | 2014-09-24 | 2018-07-31 | Kowa Company, Ltd. | Corneal thickness modulating agent |
| TWI686198B (zh) * | 2014-09-25 | 2020-03-01 | 日商興和股份有限公司 | 醫藥品 |
| PT3199160T (pt) * | 2014-09-25 | 2020-04-08 | Kowa Co | Composição aquosa |
| EP3231429B1 (en) * | 2014-12-12 | 2021-03-17 | Kowa Company, Ltd. | Aqueous composition comprising brimonidine and ripasudil |
| KR20160108121A (ko) * | 2015-03-06 | 2016-09-19 | 코와 가부시키가이샤 | 수성 조성물 |
| US9844556B2 (en) * | 2015-03-25 | 2017-12-19 | Megumi Honjo | Preventive/therapeutic method and preventive/therapeutic agent for complications after cataract surgery |
| JP6928479B2 (ja) * | 2017-05-12 | 2021-09-01 | 学校法人順天堂 | 拒絶反応抑制剤 |
-
2015
- 2015-09-25 MY MYPI2017700949A patent/MY178371A/en unknown
- 2015-09-25 US US15/514,155 patent/US20170304199A1/en not_active Abandoned
- 2015-09-25 PT PT158447375T patent/PT3199161T/pt unknown
- 2015-09-25 TW TW104131864A patent/TWI671071B/zh active
- 2015-09-25 DK DK15844737.5T patent/DK3199161T3/da active
- 2015-09-25 BR BR112017006149A patent/BR112017006149A2/pt not_active Application Discontinuation
- 2015-09-25 MX MX2017003945A patent/MX387483B/es unknown
- 2015-09-25 CA CA2962628A patent/CA2962628C/en active Active
- 2015-09-25 SG SG11201702298VA patent/SG11201702298VA/en unknown
- 2015-09-25 HU HUE15844737A patent/HUE057834T2/hu unknown
- 2015-09-25 PL PL15844737T patent/PL3199161T3/pl unknown
- 2015-09-25 ES ES15844737T patent/ES2901997T3/es active Active
- 2015-09-25 CN CN201580051710.XA patent/CN106794186B/zh active Active
- 2015-09-25 JP JP2016550378A patent/JP6244038B2/ja active Active
- 2015-09-25 EP EP15844737.5A patent/EP3199161B1/en active Active
- 2015-09-25 KR KR1020177007055A patent/KR101846804B1/ko active Active
- 2015-09-25 WO PCT/JP2015/077015 patent/WO2016047721A1/ja not_active Ceased
-
2017
- 2017-11-09 JP JP2017216093A patent/JP2018027979A/ja not_active Ceased
-
2019
- 2019-08-21 JP JP2019150781A patent/JP2020002151A/ja active Pending
-
2021
- 2021-05-06 JP JP2021078646A patent/JP2021176842A/ja active Pending
-
2023
- 2023-01-31 JP JP2023012898A patent/JP2023052792A/ja active Pending
-
2024
- 2024-03-18 US US18/608,109 patent/US20240216272A1/en active Pending
- 2024-09-30 JP JP2024169861A patent/JP2024174093A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2024174093A (ja) | 2024-12-13 |
| CA2962628A1 (en) | 2016-03-31 |
| ES2901997T3 (es) | 2022-03-24 |
| CA2962628C (en) | 2023-01-10 |
| US20240216272A1 (en) | 2024-07-04 |
| PT3199161T (pt) | 2022-02-08 |
| EP3199161A4 (en) | 2018-04-11 |
| JP2020002151A (ja) | 2020-01-09 |
| US20170304199A1 (en) | 2017-10-26 |
| KR101846804B1 (ko) | 2018-04-06 |
| JP6244038B2 (ja) | 2017-12-06 |
| WO2016047721A1 (ja) | 2016-03-31 |
| JP2023052792A (ja) | 2023-04-12 |
| TW201613603A (en) | 2016-04-16 |
| MX2017003945A (es) | 2017-06-30 |
| BR112017006149A2 (pt) | 2017-12-26 |
| TWI671071B (zh) | 2019-09-11 |
| CN106794186B (zh) | 2020-06-05 |
| PL3199161T3 (pl) | 2022-04-11 |
| CN106794186A (zh) | 2017-05-31 |
| HUE057834T2 (hu) | 2022-06-28 |
| JPWO2016047721A1 (ja) | 2017-06-22 |
| SG11201702298VA (en) | 2017-04-27 |
| JP2021176842A (ja) | 2021-11-11 |
| JP2018027979A (ja) | 2018-02-22 |
| EP3199161A1 (en) | 2017-08-02 |
| KR20170058367A (ko) | 2017-05-26 |
| DK3199161T3 (da) | 2022-01-03 |
| MY178371A (en) | 2020-10-09 |
| EP3199161B1 (en) | 2021-12-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX387483B (es) | Preparación farmacéutica. | |
| CY1120635T1 (el) | Βενζαμιδια αμινοετεροαρυλιου ως αναστολεις κινασης | |
| EA201691579A1 (ru) | Производные сульфамоилпирроламида и их применение в качестве медикаментов для лечения гепатита b | |
| EA201791304A1 (ru) | Производные изохинолина для лечения вич | |
| MA40774A (fr) | Dérivés de diaryle-urée en tant qu'inhibiteurs de kinase p38 | |
| EA201692219A1 (ru) | Способы получения противовирусных соединений | |
| CL2016001458A1 (es) | Derivado de sulfonamida o sales de adición de ácido farmaceuticamente aceptables del mismo. | |
| BR112017006253A2 (pt) | novos compostos | |
| EA201790395A1 (ru) | Производные аминотриазина, подходящие для применения в качестве соединений-ингибиторов tank-связывающей киназы | |
| CR20160099A (es) | Formulación de inhibidores de la syk | |
| MA44498A (fr) | Dérivés d'indoline substituée utilisés en tant qu'inhibiteurs de la réplication du virus de la dengue | |
| MX376283B (es) | Compuestos de imidazopiridazina. | |
| EA201691982A1 (ru) | 5,6-дизамещенные пиридин-2-карбоксамиды в качестве агонистов каннабиноидных рецепторов | |
| EA201691670A1 (ru) | Тетразолонзамещенные дигидропиридиноновые ингибиторы mgat2 | |
| CR20160016A (es) | Pirazolpiridinas sustituidas | |
| MX387796B (es) | Compuestos de aminocarbonilcarbamato. | |
| MX373700B (es) | Composicion acuosa novedosa. | |
| AR095097A1 (es) | Compuestos de fenoxietoxi | |
| EA201591915A1 (ru) | Соединения феноксиэтил дигидро-1h-изохинолина | |
| CL2018001067A1 (es) | Compuesto piranodipiridínico. | |
| EA201692270A1 (ru) | Производные нафтиридиндиона | |
| ECSP19013196A (es) | Derivado de triazolopirazinona útil como un inhibidor de pde1 humana | |
| JOP20200030A1 (ar) | مركب خماسي الحلقة | |
| EA201791396A1 (ru) | ПРОИЗВОДНЫЕ ИМИДАЗОПИРИДАЗИНА В КАЧЕСТВЕ ИНГИБИТОРОВ PI3Kβ | |
| BR112016022437A2 (pt) | Processo para preparação de (2s,5r)-6-(benziloxi)-7-oxo-1,6- diazabiciclo[3,2,1]octano-2-carboxilato de sódio |